Could Decreased Reporting of Suspected Adverse Reactions Generate Future Safety Concerns?
Autor: | Ferrara F; Asl Napoli 3 Sud, Nola, Naples, Italy., Mancaniello C; Asl Napoli 3 Sud, Nola, Naples, Italy., Nava L; Asl Napoli 2 Nord, Frattamaggiore, Naples, Italy., Salierno A; Asl Napoli 3 Sud, Nola, Naples, Italy., Casillo R; Asl Napoli 3 Sud, Nola, Naples, Italy., Trama U; Drug Policies, Campania Region, Naples, Italy., Nava E; Asl Napoli 3 Sud, Nola, Naples, Italy., Vitiello A; Usl Umbria 1, Perugia, Italy. |
---|---|
Jazyk: | angličtina |
Zdroj: | Hospital pharmacy [Hosp Pharm] 2022 Aug; Vol. 57 (4), pp. 419-421. Date of Electronic Publication: 2022 Jan 07. |
DOI: | 10.1177/00185787211069040 |
Abstrakt: | Competing Interests: Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. |
Databáze: | MEDLINE |
Externí odkaz: |